Benign fibrous dysplasia on [11C]choline PET: a potential mimicker of disease in patients with biochemical recurrence of prostate cancer

详细信息    查看全文

• 作者：Chris N. Gu (1)
  Christopher H. Hunt (2)
  Vance T. Lehman (2)
  Geoffrey B. Johnson (2)
  Felix E. Diehn (2)
  Kara M. Schwartz (2)
  Laurence J. Eckel (2)
  
• 关键词：PET/CT ; Prostate cancer ; [11C]choline ; Fibrous dysplasia
• 刊名：Annals of Nuclear Medicine
• 出版年：2012
• 出版时间：August 2012
• 年：2012
• 卷：26
• 期：7
• 页码：599-602
• 全文大小：313KB
• 参考文献：1. Hara T, Yuasa M. Automated synthesis of [11C]choline, a positron-emitting tracer for tumor imaging. Appl Radiat Isot. 1999;50:531鈥?. CrossRef
  2. Tian M, Zhang H, Oriuchi N, Higuchi T, Endo K. Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors. Eur J Nucl Med Mol Imaging. 2004;31:1064鈥?2.
  3. Khan N, Oriuchi N, Ninomiya H, Higuchi T, Kamada H, Endo K. Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET. Ann Nucl Med. 2004;18:409鈥?7. CrossRef
  4. Murphy RC, Kawashima A, Peller PJ. The utility of 11C-choline PET/CT for imaging prostate cancer: a pictorial guide. AJR Am J Roentgenol. 2011;196:1390鈥?. CrossRef
  5. Fuccio C, Rubello D, Castellucci P, Marzola MC, Fanti S. Choline PET/CT for prostate cancer: main clinical application. Eur J Radiol. 2011;80:e50鈥?. CrossRef
  6. Souvatzoglou M, Krause BJ, P眉rschel A, Thamm R, Schuster T, Buck AK, Zimmermann F, Molls M, Schwaiger M, Geinitz H. Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer. Radiother Oncol. 2011;99:193鈥?00. CrossRef
  7. Picchio M, Briganti A, Fanti S, Heidenreich A, Krause BJ, Messa C, Montorsi F, Reske SN, Thalmann GN. The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer. Eur Urol. 2011;59:51鈥?0. CrossRef
  8. Katz-Brull R, Degani H. Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method. Anticancer Res. 1996;16:1375鈥?0.
  9. Zeisel SH. Dietary choline: biochemistry, physiology, and pharmacology. Annu Rev Nutr. 1981;1:95鈥?21. CrossRef
  10. DiCaprio MR, Enneking WF. Fibrous dysplasia. Pathophysiology, evaluation, and treatment. J Bone Joint Surg Am. 2005;87:1848鈥?4. CrossRef
  11. Fitzpatrick KA, Taljanovic MS, Speer DP, Graham AR, Jacobson JA, Barnes GR, et al. Imaging findings of fibrous dysplasia with histopathologic and intraoperative correlation. AJR Am J Roentgenol. 2004;182:1389鈥?8.
  12. Su MG, Tian R, Fan QP, Tian Y, Li FL, Li L, et al. Recognition of fibrous dysplasia of bone mimicking skeletal metastasis on 18F-FDG PET/CT imaging. Skelet Radiol. 2011;40:295鈥?02. CrossRef
  13. Stegger L, Juergens KU, Kliesch S, Wormanns D, Weckesser M. Unexpected finding of elevated glucose uptake in fibrous dysplasia mimicking malignancy: contradicting metabolism and morphology in combined PET/CT. Eur Radiol. 2007;17:1784鈥?. CrossRef
  
• 作者单位：Chris N. Gu (1)
  Christopher H. Hunt (2)
  Vance T. Lehman (2)
  Geoffrey B. Johnson (2)
  Felix E. Diehn (2)
  Kara M. Schwartz (2)
  Laurence J. Eckel (2)
  
  1. University of Missouri, Columbia School of Medicine, Columbia, MO, USA
  2. Department of Radiology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA
  

文摘

We present the case of a 74-year-old male with biochemical recurrence of prostate cancer who underwent [11C]choline PET/CT. The PET/CT demonstrated an intense focus of uptake within the skull base that was initially felt to potentially represent metastatic disease. Subsequent evaluation with MRI and dedicated thin-section CT revealed this area to be benign fibrous dysplasia of the bone. The focal uptake on PET/CT with [11C]choline in benign fibrous dysplasia represents a potential mimicker of metastatic disease. Due to recognizing this benign process, our patient was able to avoid systemic treatment and/or focal radiation and was treated with cryotherapy for biopsy-proven local recurrence within the prostate bed. While benign fibrous dysplasia can demonstrate increased radiotracer uptake on other modalities (i.e., bone scintigraphy, FDG PET/CT), its appearance on [11C]choline PET/CT has been largely overlooked in the literature. With the increasing use of [11C]choline PET/CT for biochemical recurrent prostate cancer evaluation, it is important to understand this potential mimicker of disease.